Company intelligence / Profile preview

DifGen Pharmaceuticals

Princeton, New Jersey, United Statesdifgen.com ↗

Ownership: Private
Development stage: Commercial

Overview

DifGen is an integrated pharmaceutical company specializing in the development and manufacturing of complex generics across multiple dosage forms. It has expanded its capabilities through acquisitions such as Aveva Drug Delivery Systems Inc. for advanced transdermal systems and KriGen LLC for sterile drug manufacturing. The company produces over 300 million patches annually with FDA-approved facilities in the US and India. Recent clinical highlights include non-infringement wins related to ZTLido® lidocaine topical system 1.8%[1][3][10]. Clinical trial data is limited publicly.

Therapeutic areas: Dermatology
Modalities: Small molecules (complex generics)Injectables (solutions, suspensions, emulsions, lyophilized powders, liposomes, microspheres, nano-suspensions)Ophthalmic and otic products (solutions/drops, suspensions, emulsions/gels/ointments)Transdermal patches and filmsTopicals (gels/creams/ointments)Oral solids/liquids/powders/capsules/tablets/oral filmsDrug-device combinations (prefilled systems/inhalers)
Industry: Biotech

Drug pipeline

2 assets

lidocaine

Commercial

Indications: Post-herpetic neuralgia

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharma partnerships publicly listed as of May 2025.

Beyond the preview

Go deeper on DifGen Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DifGen Pharmaceuticals.

Explore the full profile